Поиск по репозиторию
Статья
A teenager with a severe form of COVID-19 [Тяжелая форма COVID-19 у подростка]
2021
In most cases children have a light form of new coronavirus infection COVID-19 as compared to adult patients; however, some children may develop severe forms of the disease. Children account for 1–11% of the confirmed patients, less than 1% of the patients have severe and extremely severe forms. The article describes a clinical case of a teenager with a severe course of COVID-19, characterized by the mismatch of physical data and a large degree of lung tissue damage, the development of hemorrhagic syndrome, low effectiveness of antibacterial and antiviral therapy, requiring Tocilizumab. © 2020 National Academy of Pediatric Science and Innovation. All rights reserved.
Цитирование
Похожие публикации
Версии
- 1. Version of Record от 2021-04-27
Метаданные
Название журнала
- Rossiyskiy Vestnik Perinatologii i Pediatrii
Том
- 65
Выпуск
- 5
Страницы
- 58-65
Ключевые слова
- antiinfective agent; antivirus agent; tocilizumab; adolescent; antibiotic therapy; antiviral therapy; Article; bleeding; case report; clinical article; clinical effectiveness; coronavirus disease 2019; disease course; disease severity; human; lung injury; lung parenchyma
Издатель
- National Academy of Pediatric Science and Innovation
Тип документа
- journal article
Тип лицензии Creative Commons
- CC
Правовой статус документа
- Свободная лицензия
Источник
- scopus
